Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034953
Filing Date
2024-11-13
Accepted
2024-11-13 16:54:39
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20240930_10q.htm   iXBRL 10-Q 759880
2 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_737799.htm EX-31.1 13555
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_737800.htm EX-31.2 15165
4 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC ex_737801.htm EX-32.1 9110
5 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC ex_737802.htm EX-32.2 7188
  Complete submission text file 0001437749-24-034953.txt   4504432

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inbp-20240930.xsd EX-101.SCH 42569
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20240930_cal.xml EX-101.CAL 30939
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20240930_def.xml EX-101.DEF 290920
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20240930_lab.xml EX-101.LAB 248284
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20240930_pre.xml EX-101.PRE 313016
61 EXTRACTED XBRL INSTANCE DOCUMENT inbp20240930_10q_htm.xml XML 684931
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 241455322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)